According to the British group#39;s chief medical officer for vaccines Thomas Breuer, who says the company prefers the slow and steady approach of focusing on an established technology that has the best chance of reaching the widest possible demographic.from Moneycontrol Business News https://ift.tt/3fEFHU2
No comments:
Post a Comment